Say No To Trading
Public Markets Investor, Opportunistic Buying & Cost-Basis Management
Nike combines more than 10 years of flat or declining share price with declining fundamentals, which rules it out as a long-term winner in a temporary slump. Microsoft's long sideways stretch was different because its fundamentals kept working. Nike could still become a major winner, but it suits concentrated investors willing to watch every development and exit quickly. Its upcoming dividend aristocrat status shouldn't be banked on; VF Corp cut just shy of 50 years of increases. x.comÂ
Nike belongs in the too-hard pile, because fashion stocks are generally best avoided and its turnaround needs babysitting. Observations about who wears Nike versus New Balance, On or Hoka hardly matter when China is the bigger factor. The stock suits turnaround specialists willing to watch it closely, not buy-and-forget investors. x.comÂ
Nike, like other apparel makers, is uninvestable because a durable moat is near impossible in this business. Consumer preferences keep changing, requiring constant new marketing to keep people excited, and making a physical product leaves an inherently low-margin business with little long-term pricing power. A major turnaround is possible, but the business model gives no confidence in its long-term strength. x.comÂ
Nike's dividend will have to be cut unless earnings double in a quick turnaround, because earnings now run below the payout. As @valuemaverick1 notes, Nike has the cash to sustain the dividend, but it does not earn it, so it should not be hiking it; that shows the Dividend Aristocrat label is worthless and the dividend a manipulated signal. Long extremely mispriced, the stock is still adjusting to new realities. The only reason to own Nike would be improving free cash flow and earnings. x.com … Show more
Nike's dividend yield, now high versus its ten-year history, is the new question for investors and makes the stock very interesting at these levels. The numbers have not bottomed, guidance was atrocious and parts of the business are getting worse, offset somewhat by better US wholesale. The guidance implies Nike will use some cash to fund the dividend, but it has plenty. The stock remains too expensive on earnings and too cheap on dividend yield. x.com x.com x.com x.com x.comÂ
Nike might not bottom until it cuts or eliminates its dividend, since net income is down 75% over five years and it cannot afford the payout. This could be one of the hardest turnarounds ever: it is getting clobbered on all fronts, China won't be coming back soon, products need a serious makeover and it overpays too many pro athletes. It needs to preserve cash, bring in new people and ideas, and find a way to bring excitement back to the brand. x.com x.comÂ
Nike keeps getting its lunch eaten by competitors, with no clear way to turn the ship around. It now expects fiscal 2027 revenue to decline by high single digits, per @negligible_cap. Caitlin Clark isn't the savior, and the stock isn't worth touching. x.com x.comÂ
Nike is the best stock to buy when others are fearful. x.comÂ
Nike is a stagnant company losing pricing power, pointing to more tough years for shareholders. Revenue fell 4% last quarter, the only line still shrinking while gross margin expanded, inventory fell 3% and North America grew 2%, per the quoted post. x.comÂ
Nike is a damaged business, not just a damaged stock, so buying the dip is a mistake; a falling price only works when the business is still growing. Sportswear, just under half of revenue, is down low double digits, China is losing ground to local brands, and guided earnings don't cover the dividend this year. Insider buying hasn't helped: Tim Cook and directors bought around $59 in December 2025, Cook and the CEO near $42 in April, and shares now sit near $32. x.com x.comÂ
Nike's valuation pays investors to wait for a turnaround that will take longer than expected. It trades at just 16x earnings, near its lowest valuation ever, with a roughly 5% dividend yield, and would need a 127% rally to regain its 200-week moving average. Revenue is projected to fall another 4% in FY2027, but the business will grow again; the market prices it as if it were disappearing. Unlike Novo Nordisk, Nike faces no patent cliff. x.com x.comÂ
Nike just can't compete the way it used to: it no longer captures the market it once did, and that clearly isn't changing any time soon. The post-earnings reaction went as expected, with the stock already at its lowest since 2014 going in. x.com x.comÂ
